Cours Tauriga Sciences, Inc. Other OTC
Actions
TAUG
US87669X2053
Produits pharmaceutiques
CA 2020 | 0,23 0,21 | CA 2021 | 0,29 0,26 | Capitalisation | 29,3 M 26,55 M |
---|---|---|---|---|---|
Résultat net 2020 | -3 M -2,72 M | Résultat net 2021 | -3 M -2,72 M | VE / CA 2020 | 15 901 203 x |
Dette nette 2020 | 373 k 338 k | Trésorerie nette 2021 | 1,04 M 941 k | VE / CA 2021 | 99 058 952 x |
PER 2020 |
-0,87
x | PER 2021 |
-6,09
x | Employés | - |
Rendement 2020 * |
-
| Rendement 2021 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 22/08/12 |
Kevin P. Lacey
DFI | Director of Finance/CFO | 55 | 05/07/17 |
Keith A. Aqua
CTO | Chief Tech/Sci/R&D Officer | - | 15/07/20 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
James V. Rosati
BRD | Director/Board Member | 74 | 08/03/21 |
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 22/08/12 |
Director/Board Member | 46 | 08/03/21 |
Varia. 1 janv. | Capi. | |
---|---|---|
+30,38% | 684 Md | |
+29,14% | 568 Md | |
-4,36% | 361 Md | |
+19,30% | 329 Md | |
+3,73% | 284 Md | |
+15,94% | 240 Md | |
+9,26% | 208 Md | |
-7,36% | 200 Md | |
+7,68% | 166 Md |